$OFIX News

Reported July 2, 2026: Orthofix Medical Says Medicare Will Restore Pre-May 18 Reimbursement Rates For Bone Growth Stimulators After CMS Reversal

Orthofix Medical (OFIX) Stock Sees Split Analyst Revisions After CMS Reimbursement Reset

Orthofix Medical Inc. (OFIX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

How The Orthofix Medical (OFIX) Narrative Is Resetting After CMS Cuts And Guidance Changes

Canaccord Genuity Maintains Buy on Orthofix Medical, Lowers Price Target to $18

Barrington Research Maintains Outperform on Orthofix Medical, Lowers Price Target to $15

Stifel Maintains Buy on Orthofix Medical, Lowers Price Target to $15

Orthofix to Participate in Upcoming Investor Conferences

Orthofix Medical Inc. (NASDAQ:OFIX) Just Reported, And Analysts Assigned A US$17.25 Price Target

Orthofix Medical Inc. 2026 Q1 - Results - Earnings Call Presentation

Orthofix Expands Pediatric Limb Reconstruction Portfolio with New FITBONE™ Innovation at POSNA 2026 Annual Meeting

Orthofix Medical Announces New Pediatric Limb Reconstruction Innovations That Expand Treatment Options For Pediatric And Small Stature Patients

Orthofix Medical Q1 Earnings Call Highlights

Orthofix Medical Inc. Q1 2026 Earnings Call Summary

Orthofix (OFIX) Q1 2026 Earnings Transcript

Orthofix Medical Inc. (NASDAQ:OFIX) Reports Mixed Q1 as Sales Miss Estimates, Loss Narrows; Full-Year Outlook Reaffirmed

Orthofix Medical Inc. (OFIX) Q1 2026 Earnings Call Transcript

Orthofix Reports First Quarter 2026 Results Highlighting Steady Execution Following Spine Commercial Channel Actions; Reaffirms Full-Year 2026 Financial Guidance

Full Transcript: Orthofix Medical Q1 2026 Earnings Call

Orthofix Medical Affirms FY2026 Sales Guidance of $850.000M-$860.000M vs $855.606M Est